Cargando…
Paclitaxel-loaded ROS-responsive nanoparticles for head and neck cancer therapy
High intracellular reactive oxygen species (ROS) level is characteristic of cancer cells and could act as a target for the efficient targeted drug delivery for cancer treatment. Consequently, biomaterials that react to excessive levels of ROS are essential for biomedical applications. In this study,...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026753/ https://www.ncbi.nlm.nih.gov/pubmed/36916054 http://dx.doi.org/10.1080/10717544.2023.2189106 |
_version_ | 1784909580217614336 |
---|---|
author | Tu, Yaqin Zhang, Wei Fan, Guorun Zou, Chenming Zhang, Jie Wu, Nan Ding, Jiahui Zou, Wen Qing Xiao, Hongjun Tan, Songwei |
author_facet | Tu, Yaqin Zhang, Wei Fan, Guorun Zou, Chenming Zhang, Jie Wu, Nan Ding, Jiahui Zou, Wen Qing Xiao, Hongjun Tan, Songwei |
author_sort | Tu, Yaqin |
collection | PubMed |
description | High intracellular reactive oxygen species (ROS) level is characteristic of cancer cells and could act as a target for the efficient targeted drug delivery for cancer treatment. Consequently, biomaterials that react to excessive levels of ROS are essential for biomedical applications. In this study, a novel ROS-responsive polymer based on D-α-Tocopheryl polyethylene glycol 1000 succinate (TPGS) and poly (β-thioester) (TPGS-PBTE) was synthesized for targeted delivery of the first-line antineoplastic drug, paclitaxel (PTX). The resultant TPGS-PBTE NPs showed good ROS-responsive capability in size change and drug release. Compared to PTX, PTX-loaded nanoparticles (PTX@TPGS-PBTE NPs) showed enhanced cytotoxicity and higher level of apoptosis toward squamous cell carcinoma (SCC-7) cells. Tumor-targeted delivery of the NPs was also observed, especially after being modified with a tumor-targeting peptide, cRGD. Enhanced tumor growth inhibition was also observed in head and neck cancer SCC-7 murine models. In summary, PTX@TPGS-PBTE NPs can achieve good therapeutic effects of PTX against head and neck cancer both in vitro and in vivo, especially when modified by cRGD for active targeting, which enriched the application of ROS responsive system utilized in the delivery of anticancer drugs. |
format | Online Article Text |
id | pubmed-10026753 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-100267532023-03-21 Paclitaxel-loaded ROS-responsive nanoparticles for head and neck cancer therapy Tu, Yaqin Zhang, Wei Fan, Guorun Zou, Chenming Zhang, Jie Wu, Nan Ding, Jiahui Zou, Wen Qing Xiao, Hongjun Tan, Songwei Drug Deliv Research Article High intracellular reactive oxygen species (ROS) level is characteristic of cancer cells and could act as a target for the efficient targeted drug delivery for cancer treatment. Consequently, biomaterials that react to excessive levels of ROS are essential for biomedical applications. In this study, a novel ROS-responsive polymer based on D-α-Tocopheryl polyethylene glycol 1000 succinate (TPGS) and poly (β-thioester) (TPGS-PBTE) was synthesized for targeted delivery of the first-line antineoplastic drug, paclitaxel (PTX). The resultant TPGS-PBTE NPs showed good ROS-responsive capability in size change and drug release. Compared to PTX, PTX-loaded nanoparticles (PTX@TPGS-PBTE NPs) showed enhanced cytotoxicity and higher level of apoptosis toward squamous cell carcinoma (SCC-7) cells. Tumor-targeted delivery of the NPs was also observed, especially after being modified with a tumor-targeting peptide, cRGD. Enhanced tumor growth inhibition was also observed in head and neck cancer SCC-7 murine models. In summary, PTX@TPGS-PBTE NPs can achieve good therapeutic effects of PTX against head and neck cancer both in vitro and in vivo, especially when modified by cRGD for active targeting, which enriched the application of ROS responsive system utilized in the delivery of anticancer drugs. Taylor & Francis 2023-03-14 /pmc/articles/PMC10026753/ /pubmed/36916054 http://dx.doi.org/10.1080/10717544.2023.2189106 Text en © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent. |
spellingShingle | Research Article Tu, Yaqin Zhang, Wei Fan, Guorun Zou, Chenming Zhang, Jie Wu, Nan Ding, Jiahui Zou, Wen Qing Xiao, Hongjun Tan, Songwei Paclitaxel-loaded ROS-responsive nanoparticles for head and neck cancer therapy |
title | Paclitaxel-loaded ROS-responsive nanoparticles for head and neck cancer therapy |
title_full | Paclitaxel-loaded ROS-responsive nanoparticles for head and neck cancer therapy |
title_fullStr | Paclitaxel-loaded ROS-responsive nanoparticles for head and neck cancer therapy |
title_full_unstemmed | Paclitaxel-loaded ROS-responsive nanoparticles for head and neck cancer therapy |
title_short | Paclitaxel-loaded ROS-responsive nanoparticles for head and neck cancer therapy |
title_sort | paclitaxel-loaded ros-responsive nanoparticles for head and neck cancer therapy |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026753/ https://www.ncbi.nlm.nih.gov/pubmed/36916054 http://dx.doi.org/10.1080/10717544.2023.2189106 |
work_keys_str_mv | AT tuyaqin paclitaxelloadedrosresponsivenanoparticlesforheadandneckcancertherapy AT zhangwei paclitaxelloadedrosresponsivenanoparticlesforheadandneckcancertherapy AT fanguorun paclitaxelloadedrosresponsivenanoparticlesforheadandneckcancertherapy AT zouchenming paclitaxelloadedrosresponsivenanoparticlesforheadandneckcancertherapy AT zhangjie paclitaxelloadedrosresponsivenanoparticlesforheadandneckcancertherapy AT wunan paclitaxelloadedrosresponsivenanoparticlesforheadandneckcancertherapy AT dingjiahui paclitaxelloadedrosresponsivenanoparticlesforheadandneckcancertherapy AT zouwenqing paclitaxelloadedrosresponsivenanoparticlesforheadandneckcancertherapy AT xiaohongjun paclitaxelloadedrosresponsivenanoparticlesforheadandneckcancertherapy AT tansongwei paclitaxelloadedrosresponsivenanoparticlesforheadandneckcancertherapy |